Comparison of the efficacy and the safety of two imidazoline receptors agonists: Rilmenidine and moxonidine;Comparaison de l'efficacité antihypertensive et de la tolérance de deux agonistes des récepteurs aux imidazolines, la moxonidine et la rilmenidine administrées en monothérapie

Annales de Cardiologie et d'Angeiologie

Volumn 50, Issue 3, 2001, Pages 169-174

  Camilleri, G ^a   Portal, B ^a   Quiniou, G ^a   Clerson, P ^b  

^a HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

^b Orgametrie   (France)

Author keywords

Clinical trial; Hypertension; I1 receptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE I1 RECEPTOR AGONIST; MOXONIDINE; RILMENIDINE; UNCLASSIFIED DRUG; DRUG RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTORS; OXAZOLE DERIVATIVE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RECEPTOR AFFINITY; SOMNOLENCE; URTICARIA; COMPARATIVE STUDY; DRUG POTENTIATION; HOSPITALIZATION; MIDDLE AGED;

ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; OXAZOLES; RECEPTORS, DRUG; SEVERITY OF ILLNESS INDEX;

EID: 0035048073     PISSN: 00033928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-3928(01)00017-8     Document Type: Short Survey

References (30)

1. The renaissance of centrally acting antihypertensive drugs
2. Monoxidine decreases both cardiac and peripheral sympathetic activity in healthy volunteers
3. Moxonidine a centrally acting antihypertensive agent is a selective ligand for I1-imidazoline sites
4. Effects of moxonidine on stress-induced peak blood pressure and renal function: A randomised, double-blind, placebo-controlled crossover study
5. Demonstration of hypertrophy regression with magnetic resonance tomography under the new adrenergic inhibitor monoxidine
6. Linksventrikuläre hypertrophieregression unter einer therapie mit moxonidin
7. Moxonidine improves insulin sensitivity in insulinresistant hypertensives
8. Drugs acting on imidazoline receptors: A review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection
9. Centrally acting antihypertensive drugs. Present and future
10. Clinical pharmacology of moxonidine
11. Twenty four hour blood pressure profiles in patients with mild to moderate hypertension moxonidine versus captopril
12. Doppelblind crossover vergleich von moxonidine und clonidin-HCI
13. Intraindividual comparison of moxonidine and prazosin in hypertensive patients
14. Comparison of the effects of moxonidine and nifedipine on left ventricular function when given as monotherapy for essential hypertension
15. A double blind comparison od moxonidine and atenolol in the management of patients with mild to moderate hypertension
16. Moxonidine and hydrochlorothiazide in combination: A synergistic antihypertensive effect
17. ZNS-effekte von moxonidin einem neuen zentralnervos wirkenden antihypertensivum, im vergleich zu clonidin und placebo
18. Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertensive patients
19. I1-imidazoline agonist monoxidine decreases sympathetic nerve activity and blood pressure in hypertensives
20. Dose and concentration-effect relations for rilmenidine
21. Efficacy and acceptability of rilmenidine
22. A multicenter double-blind comparative study of rilmenidine and clonidin in 333 hypertensive patients
23. Rilmenidine in patients with left ventricular hypertrophy: Beyond the reduction of left ventricular mass
24. Long term control of blood pressure in high risk population
25. Hypertension awareness, treatment and control in the community: Is the rule of «halves» still valid?
26. Blood pressure screening, management and control in England: Results from the health survey for England 1994
27. Blood pressure control in the hypertensive population
28. 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension